ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND THEIR USES
CY1126313T1Undetermined Publication Date: 2026-07-31ELI LILLY & CO
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100537T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-07-01
- Filing Date
- 2023-10-04
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-10-04
Abstract
The invention is directed to a short-term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by Aβ deposition in the brain, including Alzheimer's disease (AD), Down syndrome, and cerebral amyloid angiopathy (CAA). In some embodiments, patients are administered an induction dose of 10 to 60 mg / kg of an anti-N3pGlu Aβ antibody for a period of 6 months or less.
Need to check novelty before this filing date? Find Prior Art